• 信息
  • 详情
  • 联系
  • 推荐
分享好友 产品首页 产品分类 切换频道
1/5
Human VEGF R2/KDR Allophycocyanin MAb (Clone 89106)  100 TESTS图1

Human VEGF R2/KDR Allophycocyanin MAb (Clone 89106) 100 TESTS

2024-11-24 17:35IP属地 广东省东莞市 电信00留言

Applications

Please Note: Optimal dilutions should be determined by each laboratory for each application.  are available in the Technical Information section on our website.

Data Examples

Flow Cytometry      
     

Detection of VEGF R2/KDR/Flk‑1 in HUVEC Human Cells by Flow Cytometry. HUVEC human umbilical vein endothelial cells were stained with Mouse Anti-Human VEGF R2/KDR/Flk‑1 APC‑conjugated Mono­clonal Antibody (Catalog # FAB357A, filled histogram) or isotype control antibody (Catalog # , open histogram). View our protocol for .

Preparation and Storage

Background: VEGF R2/KDR/Flk-1

VEGF R2 (KDR/Flk-1), VEGF R1 (Flt-1) and VEGF R3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domains and kinase insert domains in their intracellular regions. The expression of VEGF R1, 2, and 3 is almost exclusively restricted to the endothelial cells. These receptors are likely to play essential roles in vasculogenesis and angiogenesis. Mature VEGF R2 is composed of a 745 aa extracellular domain, a 25 aa transmembrane domain and a 567 aa cytoplasmic domain. In contrast to VEGF R1 which binds both PlGF and VEGF with high affinity, VEGF R2 binds VEGF but not PlGF with high affinity. The recombinant soluble VEGF R2/Fc chimera binds VEGF with high affinity and is a potent VEGF antagonist.

举报
收藏 0
评论 0
联系方式